Filter
1111
Filtered Results: 1111
Text search:
vaccine
trial
Featured
Recommendations
139
New Publications
237
Language
Document type
No document type
479
Studies & Reports
208
Guidelines
192
Manuals
68
Fact sheets
65
Strategic & Response Plan
41
Situation Updates
18
Training Material
14
Resource Platforms
12
Infographics
6
Videos
5
Brochures
2
App
1
Countries / Regions
Global
51
India
37
Kenya
26
Sierra Leone
25
South Africa
23
Liberia
21
Nigeria
21
West and Central Africa
18
Ethiopia
17
Western and Central Europe
17
Brazil
16
East and Southern Africa
16
Uganda
14
Africa
14
Latin America and the Carribbean
13
Congo, Democratic Republic of
11
Eastern Europe
11
Russia
10
Guinea
9
Ghana
9
Zambia
9
Ukraine
9
South Sudan
8
Rwanda
8
Malawi
8
Philippines
7
Nepal
7
Germany
7
Tanzania
7
Mozambique
7
Middle East and North Africa
7
South–East Asia Region
7
Zimbabwe
6
Syria
6
Bangladesh
6
Cambodia
4
Namibia
4
Myanmar / Burma
4
Asia
4
Vietnam
4
Burkina Faso
3
Senegal
3
USA
3
Lebanon
3
Thailand
3
Indonesia
3
Chile
3
Eastern Europe and Central Asia
3
Paraguay
3
United Kingdom
3
Guinea-Bissau
2
Cameroon
2
Jordan
2
Turkey
2
China
2
Sudan
2
Argentina
2
Botswana
2
Angola
2
Lesotho
2
Spain
2
Mali
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Niger
1
Haiti
1
Pakistan
1
Iraq
1
Gambia
1
Malaysia
1
Papua New Guinea
1
Central African Republic
1
Peru
1
Eswatini/ Swaziland
1
Honduras
1
Ecuador
1
Yemen
1
Western Pacific Region
1
Venezuela
1
Southern Africa
1
Laos
1
Bulgaria
1
Gabon
1
Japan
1
France
1
Tunisia
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
296
Clinical Guidelines
145
Women & Child Health
64
Public Health
58
Key Resources
23
Pharmacy & Technologies
14
Capacity Building
4
Toolboxes
COVID-19
282
TB
91
HIV
81
Ebola
67
Rapid Response
55
NTDs
44
AMR
31
Pharmacy
26
Global Health Education
16
Refugee
15
Mental Health
15
Planetary Health
14
Health Financing Toolbox
14
Conflict
12
NCDs
12
Polio
11
Zika
11
Caregiver
11
Cholera
10
Disability
2
Natural Hazards
1
A practitioner’s guide to the principles of COVID-19 vaccine communications.
The factors that lead people to make choices to take vaccines are nuanced and affected by how they see the world, their perceptions of the choices people like them wil...
first issued 18 August 2022
Protection from a Single Dose of HPV Vaccine A major public health impact from IARC studies of vaccine efficacy.
17 Febr. 2022. As part of the “Strategy to Achieve Global COVID-19 Vaccination by mid-2022”, global targets of 40% population coverage by end of 2021 and 70% coverage by June 2022 have been set by the World Health Organization (WHO), to successfully prevent severe illness and deaths, minimize so...
Mass vaccination campaigns to prevent coronavirus disease 2019 (Covid-19) are occurring in many countries; estimates of vaccine effectiveness are urgently needed
to support decision making. A countrywide mass vaccination campaign with the
use of...
Interim Guidance, 12 July 2021; This tool was developed to assess present and surge capacities for the treatment of COVID-19 in health facilities. It allows health facilities to assess the availability and status of stockout of critical COVID-19 medicines, equipment and supplies on site and to ident...
This article was published on December 10, 2020, and updated on December 16, 2020, at NEJM.org. DOI: 10.1056/NEJMoa2034577
These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and a...
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start of the pa...
The current SEARVAP (South-East Asia regional vaccine action plan) describes a set of regional goals and objectives for immunization and control of vaccine-preventable diseases for 2016 – 2020 and...
REG 174 INFORMATION FOR UK HEALTHCARE PROFESSIONALS
Herd immunity by mass vaccination offers the potential to substantially limit the continuing spread of COVID-19, but high levels of vaccine hesitancy threaten this goal. In a cross-country analysis of vacc... hesitant respondents across Latin America in January 2021, we experimentally tested how five features of mass vaccination campaigns—the vaccine’s producer, efficacy, endorser, distributor, and current population uptake rate—shifted willingness to take a COVID-19 vaccine. We find that citizens preferred Western-produced vaccines, but were highly influenced by factual information about vaccine efficacy. Vaccine hesitant individuals were more responsive to vaccine messengers with medical expertise than political, religious, or media elite endorsements. Citizen trust in foreign governments, domestic leaders, and state institutions moderated the effects of the campaign features on vaccine acceptance. These findings can help inform the design of unfolding mass inoculation campaigns.
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence s...
Clinical Medicine
JCI Insight. 2017;2(7):e91963.
An example of integration of research into epidemic response.
